| 摘要 |
Described herein is the isolation of colicin-producing strains of E. coli for use as probiotic treatments for the prevention of E. coli K88+diarrhea. These strains of E. coli, designated as UM-17, and UM-19, express a filament and produce colicin but produce no compounds toxic to the host animal and as such inhibit the growth of E. coli K88+.
|
